Get the app
public
ios_share
JAMA Editors' Summary
chevron_right
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
May 9, 2017
07:44
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
May 09, 2017 edition of the weekly JAMA Editors' Summary